Director Patrick Lepore acquired a total of 50,000 shares at an average price of $0.54. To acquire these shares, it cost $27 thousand.
What’s Happening: Lannett entered into an agreement with Areva Pharmaceuticals to be the exclusive the U.S. distributor of fludarabine phosphate for Injection, USP, 50 mg/2mL, single-dose vials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.